Balkrishna Paper Mills Limited Overview
Note on founding year.
-
The CRISIL "incorporated 1961" and Screener "1975" dates most plausibly describe the legacy paper-board operation at Ambivali, which was historically part of the Balkrishna group (Balkrishna Industries Limited).
-
They do not describe the current legal entity. That entity was incorporated in June 2013 and received the paper-board undertaking on 10 February 2015 under a court-sanctioned scheme of arrangement.
Balkrishna Paper Mills Limited is a Mumbai-headquartered micro-cap belonging to the Siyaram–Poddar business group. It was carved out of Balkrishna Industries in 2015 to house the group's coated duplex and triplex paperboard manufacturing at Ambivali, Maharashtra. For most of its listed life the company made recycled-fibre packaging board for FMCG, pharmaceutical, garment, food and matchbox customers. Its scale was modest (peak revenue about ₹242 Cr in FY2022) and losses were chronic. In November 2024 the board ruled that Ambivali manufacturing was unviable, and the plant was classified as a discontinued operation. Today BPML is effectively a shell in transition. It generates under ₹5 Cr a year from trading paper and paperboard, carries roughly ₹166 Cr of borrowings and preference-share liabilities, and reports a negative net worth of ₹175 Cr. It depends on promoter-group inter-corporate deposits. Its forward thesis rests on three things: a capital-reduction scheme, monetising Ambivali assets, and a newly approved entry into real estate development.
What the company does today
BPML's operating activity in FY2026 consisted almost entirely of trading in paper and paperboard.
-
Revenue from operations was ₹473.22 lakh (₹4.73 Cr) in FY2026.
-
Purchases of stock-in-trade were ₹440.26 lakh, so the company earned a thin trading spread of about 7% before overheads (FY2026 audited results, NSE iXBRL, 22 May 2026).
-
The second reportable segment, Trading of plastic & packaging materials, recorded nil revenue in both FY2025 and FY2026.
The former core business, Manufacturing of Paper and Paper Board at Ambivali, is reported as a discontinued operation under Ind AS 105. The board decided to discontinue it at its meeting on 13 November 2024.
-
The board's stated reasons were heavy and persistent losses from high production costs, low productivity, low business volumes and high fixed costs (S&P Capital IQ via MarketScreener, 13 Nov 2024).
-
The FY2025 Directors' Report adds that an external consultant concluded Ambivali manufacturing was not viable. The consultant pointed to evolving market conditions, rising competition and changing consumer preferences toward digital alternatives (Directors' Report FY2025, via IIFL).
-
The same summary notes that the Ambivali plant and machinery had become obsolete (IIFL company summary).
Company's own description
The latest filings describe the business narrowly. In the going-concern note to the FY2026 results:
-
The company says it is engaged in trading paper and paperboard.
-
It says it is "confident to improve the paper and paper board business in the ensuing period."
-
It says it can explore other available resources to generate future cash flow (FY2026 audited results, Note 3).
The company's older self-description emphasised packaging board serving pharmaceuticals, cosmetics, healthcare products, readymade garments, food products, matchboxes and, mainly, FMCG customers (MarketsMojo / IIFL company profile). Screener's synthesis, drawn from a CRISIL rationale and the FY2025 annual report, says:
-
BPML formerly made coated duplex/triplex board from recycled wastepaper and pulp at Ambivali.
-
It now trades sustainable plastic and packaging materials and paper and paperboard.
-
It is examining new lines of business to make better use of its existing resources.
Business model and revenue model
| Dimension | Characterisation (FY2026) |
|---|---|
| Revenue model | 100% product trading (resale of paper and paperboard). No service, subscription or licensing revenue. |
| Value-chain position | Distributor/trader between mills and packaging converters; formerly an integrated recycled-fibre board manufacturer |
| Customer types | B2B: packaging converters, printers, carton makers (historically FMCG, pharma, garments, food, matchbox end-users) |
| End-markets | Indian domestic packaging. Exports were material until FY2023 (₹58 Cr) and nil from FY2024. |
| Asset intensity | Near zero operating assets. Property, plant and equipment was ₹37.43 lakh at 31 March 2026, against ₹1,526.81 lakh of assets held for sale (Ambivali disposal group). |
| Funding model | Promoter-group inter-corporate deposits (ICDs) and preference capital. No bank debt since CRISIL withdrew its rating in October 2024 on receipt of the lender's no-dues certificate. |
Independent characterisation
Analytically, BPML is no longer a paper company in any economic sense. It is a financially distressed listed shell with three characteristics:
-
A sub-scale trading activity that cannot cover finance costs. FY2026 finance costs of ₹607.95 lakh were 1.28× revenue.
-
A disposal group of residual Ambivali assets, including machinery under a ₹13.62 Cr sale agreement.
-
A promoter group that keeps funding it through ICDs while restructuring its capital.
The equity's value rests on three questions:
-
Can the NCLT-sanctioned capital reduction clean up the balance sheet?
-
Can land or other "available resources" (a phrase management repeats) be monetised, likely through the newly approved real estate development activity?
-
Will the promoter group keep subordinating its claims?
The trading turnover is a going-concern signal rather than a value driver.
Strategy
Stated strategy (themes from latest filings)
Management's stated strategy, distilled from the FY2025 Directors' Report, the FY2026 going-concern note and 2026 board outcomes, has three pillars:
-
Grow paper and paperboard trading. The company highlights its "rich experience" in the paper and paperboard business. It cites FY2026 turnover of ₹473.22 lakh against ₹232.36 lakh in FY2025 as "significant growth" (FY2026 results Note 3).
-
Monetise existing resources. Management refers repeatedly to "various other resources that can be put to optimum utilisation for generating future cash flows" (Q3 FY2026 Note 3), which in practice means the Ambivali assets.
-
Diversify into new businesses. The Object Clause was altered in December 2023. In April 2026 the board approved entry into real estate development and allied activities.
Initiatives register (last 24 months)
| Date | Initiative | Detail | Targets / financial parameters | Status |
|---|---|---|---|---|
| Apr–May 2024 | Rights issue and preference redemption | ₹45.11 Cr raised at ₹21/share; ₹25 Cr 9% CRPS redeemed | Deleveraging | Completed |
| Oct 2024 | Exit from bank borrowing | CRISIL rating withdrawn on banker's no-dues certificate | Bank debt eliminated | Completed |
| 13 Nov 2024 | Discontinue Ambivali manufacturing | Ind AS 105 discontinued operation | Stop operating losses | Completed |
| 13 Feb 2025 → Mar 2026 | Disposal of Ambivali machinery | Sale to Symcom Exim Pvt Ltd (unrelated party) at ₹13,61,80,000 + GST; advance ₹2,72,36,000 received 12 Mar 2026 | ₹13.62 Cr inflow | In progress. Assets held for sale were ₹15.27 Cr at 31 Mar 2026. |
| 23 Dec 2025 | Scheme of Reduction of Share Capital | Equity FV ₹10→₹1 across 3,22,19,532 shares; accumulated losses set off first against Securities Premium (₹23.29 Cr), then against equity capital (₹28.10 Cr per scheme figures). ₹110 Cr preference capital cancelled; consideration treated as an unsecured, non-interest-bearing loan until funds permit. | Accumulated losses reduced from ₹278.39 Cr to ₹226.11 Cr | Approved by preference holders (19 Jun 2026) and equity holders (postal ballot 2 Jul 2026). Exchanges issued "return letters" on the scheme application (22 Apr 2026). NCLT sanction pending; current status of exchange no-objection not confirmed. |
| 10 Apr 2026 | Entry into real estate development | Residential and commercial development and allied activities; strategic focus on land monetisation | Investment "to be determined" | Approved; no project disclosed |
| 10 Apr 2026 | Related-party ICD facilities | Up to ₹25 Cr each from S P Finance & Trading Ltd and Sanchna Trading & Finance Ltd in FY2027 and again in FY2028 (₹100 Cr aggregate headroom); up to 12% p.a.; unsecured; 1-year tenor, extendable | Funds working capital, debt repayment and real-estate business | Shareholder approval obtained 2 Jul 2026 |
| FY2026 | Investment-property transactions | ₹180 lakh purchase, ₹50 lakh sale of investment property | — | Executed |
Sustainability and ESG commitments: none disclosed.
Cost programmes: no formal programme with targets. Operating cost has fallen as a by-product of closing the mill.
Management medium-term targets and guidance
Not publicly disclosed. The company does not issue financial guidance, holds no earnings calls and publishes no investor presentations, per the retrieved exchange filings.
Products & Services
Current portfolio (FY2026–FY2027)
| Segment | Offering | Description | Target customer | Status | Pricing model |
|---|---|---|---|---|---|
| Paper & Paper Board (trading) | Traded paper and paperboard | Resale of paper and board sourced from third-party mills. FY2026 purchases ₹440.26 lakh against sales ₹473.22 lakh. | Packaging converters, printers | Active; FY2026 revenue ₹473.22 lakh | Transactional spot sales; not disclosed |
| Trading of plastic & packaging | "Sustainable" plastic and packaging materials | Trading of plastic and packaging inputs | Packaging users | Dormant; nil revenue FY2025–FY2026. Segment assets were ₹35 lakh at Mar 2025 and nil at Mar 2026. | — |
| Real estate (proposed) | Residential and commercial development and allied activities | Board-approved 10 Apr 2026 under sub-clause 3 of Clause III(A) of the Memorandum. Investment size to be decided on project feasibility. | Property buyers / lessees | Pre-revenue; no project announced | — |
Legacy manufactured portfolio (discontinued November 2024)
| Product (legacy brand) | Description | Typical end-use |
|---|---|---|
| Eco Board (HWC) | Coated duplex board, grey back (HWC grade) | FMCG cartons, matchboxes |
| Eco–White Board (HWC) | Coated board, white-top variant | Consumer packaging |
| Eco Kraft Back Board (HWC) | Coated board with kraft back | Heavier cartons |
| Duplex Coated Board (DCB) | Standard coated duplex board | Pharma, FMCG, garments |
| Super Chromo Board (White Back) | Premium coated board, white back (triplex-type) | Cosmetics, premium FMCG |
| Super Chromo Board (White Back–Premium) | Premium grade of the above | High-end printing and packaging |
| Super Chromo Board (White Shade) | White-shade premium grade | Premium packaging |
MarketScreener's business description lists the product range made at Ambivali from recycled wastepaper and pulp. All of these products were discontinued in FY2025.
Specifications (GSM range, brightness, bulk), launch years and pricing for these grades are not publicly disclosed in retrieved sources. Ambivali's installed capacity is also not disclosed in retrieved sources.
Financial Narrative
Data basis and caveats
-
Figures are standalone, in ₹ Cr, from Screener.in (C-MOTS data) and cross-checked to the FY2026 audited results (NSE iXBRL, 22 May 2026) and FY2025 audited figures (Q3 FY2026 filing).
-
FY2024 onward is on a continuing-operations basis for revenue and operating lines. Net profit includes discontinued operations.
-
FY2022 and FY2023 include the then-operating Ambivali mill.
-
These differences make year-on-year comparisons across FY2023 to FY2024 structurally discontinuous.
Income statement (₹ Cr)
Sources: Screener.in standalone P&L; gross profit from StockAnalysis (₹ million converted to ₹ Cr); EBIT is analyst-derived (operating profit less depreciation).
Margin profile (%)
Analyst calculations. EBITDA margin as reported by Screener (OPM). Net margins in FY2024–FY2026 are dominated by exceptional and discontinued items and finance costs on a tiny revenue base, so they carry little analytical signal.
Revenue CAGR.
-
FY2022→FY2026 4-year revenue CAGR: –62.6% (analyst calculation).
-
Screener reports 5-year sales CAGR of –48% and 3-year of –65%.
FY2026 detailed P&L (₹ lakh, audited)
Source: FY2026 audited results iXBRL, NSE, 22 May 2026. The FY2026 discontinued pre-tax loss of ₹135.04 lakh became a ₹36.96 lakh profit after a ₹172.00 lakh tax credit.
Anatomy of the FY2025 "profit" (₹ lakh)
Source: Q3 FY2026 results, Note 5 (FY2025 audited column): The FY2025 net profit of ₹818.65 lakh was therefore an accounting outcome:
-
Excluding exceptional items, the loss before tax was ₹876.43 lakh.
-
The largest component was the reversal of previously accrued preference dividends, which is non-cash.
-
In Q3 FY2026 a further ₹193.27 lakh exceptional gain came from "sundry credit balances written back".
Balance sheet (₹ Cr, 31 March)
Sources: Screener.in balance sheet; cash from StockAnalysis; FY2026 confirmed to audited Statement of Assets & Liabilities (net worth –₹17,544.16 lakh). FY2025 net worth –₹16,892.83 lakh per the Mar 2026 Reg 30 disclosure. Net debt is analyst-derived. FY2026 intangibles ₹3.06 lakh.
Debt composition at 31 March 2026 (₹ lakh, audited).
Debt composition — analyst interpretation (not company-confirmed).
-
Current borrowings of ₹2,355 lakh reconcile exactly to the two related-party ICDs outstanding at year-end: S P Finance & Trading Ltd ₹1,800 lakh and Sanchna Trading & Finance Ltd ₹555 lakh (H2 FY2026 RPT disclosure).
-
Non-current borrowings of ₹14,250 lakh very likely include the ₹11,000 lakh of 6.5% non-cumulative redeemable preference shares, classified as a financial liability under Ind AS 32. The balance (about ₹3,250 lakh) is not itemised in retrieved sources.
Working capital and liquidity (31 March 2026).
-
Current assets: ₹217.96 lakh. Current liabilities: ₹2,681.52 lakh.
-
Working capital: –₹2,463.56 lakh (–₹24.6 Cr).
-
Current ratio: 0.08×. Including assets held for sale and associated liabilities, it is about 0.52×.
-
Cash, bank and current investments totalled ₹170.51 lakh.
Cash flow (₹ Cr)
Source: Screener.in. Screener's "free cash flow" appears to net asset-disposal proceeds against operating cash flow, so it is not a pure CFO-minus-capex measure.
-
Net cash used in operating activities was ₹156.60 lakh (–₹1.57 Cr), not –₹4.29 Cr.
-
Investing inflow was ₹5.36 lakh, comprising PPE sale proceeds ₹134.37 lakh, investment-property sale ₹50.00 lakh, investment-property purchase –₹180.00 lakh, and interest received ₹2.17 lakh.
-
Financing inflow was ₹88.40 lakh: borrowings raised ₹3,500 lakh, repaid ₹2,895 lakh, and other outflows (likely interest) ₹515.27 lakh.
-
Cash fell from ₹82.23 lakh to ₹19.39 lakh.
Capex was nil in FY2026 (purchase of PPE ₹0).
FY2026 investment property. The FY2026 statement shows a ₹180 lakh purchase of investment property and a ₹50 lakh sale. This is the first cash footprint of real-estate activity, preceding the April 2026 formal board approval to enter real estate.
Ratio analysis
Analyst calculations, plus Screener for days ratios. Screener leaves ROCE blank for FY2025 and FY2026; zero values in the table mean "not reported", not 0%.
Ratios that are not meaningful.
ROE and debt/equity: are not meaningful because shareholders' equity has been negative in every year shown.
ROIC: turns not meaningful from FY2024 because invested capital (equity plus debt) became negative: –₹6.68 Cr in FY2024, –₹8.89 Cr in FY2025 and –₹9.35 Cr in FY2026. Earlier ROIC was –11.1% in FY2022 and –56.4% in FY2023.
Net debt/EBITDA: is not meaningful (negative EBITDA in all years).
Recent quarterly trajectory (₹ Cr)
Source: Screener.in quarterly standalone. Q1 FY2027 is the quarter ended 30 June 2026. Q2 FY2027 results were pending at the cut-off; the trading window has been closed since 1 October 2026.
Commentary on trends, inflections and drivers
1. FY2022–FY2023: the manufacturing collapse.
-
FY2022 revenue peaked at ₹242 Cr, of which exports were ₹114.65 Cr (MarketScreener geographic data). That year still showed an operating loss of ₹5.6 Cr. The reported net loss was held to ₹4.7 Cr only by a ₹13.55 Cr gain on sale of immovable property.
-
FY2023 revenue halved and the operating loss widened to ₹35 Cr.
-
The drivers cited by management are consistent: high cost of production, low productivity, high fixed costs, and a market moving toward integrated, virgin-fibre and larger recycled-board producers.
2. FY2024: write-downs.
-
Fixed assets fell from ₹120.88 Cr to ₹26.81 Cr.
-
Other income of –₹62.91 Cr shows impairments and losses on assets.
-
The net loss peaked at ₹71.14 Cr and net worth troughed at –₹221.88 Cr.
3. FY2025: a balance-sheet event, not an operating recovery.
-
The ₹45.11 Cr rights issue lifted equity capital to ₹32.22 Cr and funded the redemption of ₹25 Cr of 9% preference shares.
-
That redemption allowed ₹14.95 Cr of accrued preference dividend to be written back. Together with a ₹9.10 Cr asset-sale gain, this produced a ₹8.19 Cr reported profit.
-
Borrowings fell by ₹55 Cr.
4. FY2026: steady-state cash burn.
-
With manufacturing gone, the structural run-rate is clear: revenue of about ₹4–5 Cr, EBITDA of about –₹0.9 Cr, and finance cost of about ₹6 Cr.
-
The result is a recurring pre-tax loss of ₹6.5–7 Cr a year, funded by promoter ICDs.
5. The key inflection ahead is capital structure, not operations.
-
If the NCLT sanctions the scheme, ₹110 Cr of preference capital becomes a non-interest-bearing unsecured loan. This could cut reported finance costs materially, assuming much of the current finance cost is imputed on the preference liability (analyst inference).
-
Equity capital would shrink to ₹3.22 Cr, and accumulated losses would fall from ₹278.39 Cr to ₹226.11 Cr (scheme figures, 30 Sep 2025 basis).
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Segment revenue (INR Lakh)
| Segment revenue (INR Lakh) | FY2025 | FY2026 |
|---|---|---|
Paper and Paper Board trading (continuing) | 232.36 | 473.22 |
Trading of plastic and packaging materials (continuing) | 0 | 0 |
Ambivali manufacturing (discontinued) | 54.64 | 0 |
Gross value of sales incl. discontinued | 287.00 | 473.22 |
Segment EBIT (INR Lakh)
| Segment EBIT (INR Lakh) | FY2025 | FY2026 |
|---|---|---|
Paper and Paper Board trading (continuing) | -78.80 | -80.64 |
Ambivali manufacturing (discontinued) | -211.94 | -135.04 |
Total segment EBIT | -290.74 | -215.68 |
Finance costs | 585.69 | 607.95 |
Segment Margins & Growth (%) and Revenue by Segment (%)
| Metric | FY2025 | FY2026 |
|---|---|---|
Paper trading segment EBIT margin (%) | -33.9 | -17.0 |
Paper trading revenue YoY growth (%) | — | 103.7 |
Paper trading share of continuing revenue (%) | 100 | 100 |
Paper trading share of gross sales incl. discontinued (%) | 81.0 | 100 |
Segment Overview
| Segment | Assets | Liabilities (as filed) |
|---|---|---|
Paper and Paper Board | 258.63 | 1,142.23 |
Trading of plastic & packaging | 0.00 | 0.00 |
Ambivali (discontinued, held for sale) | 1,526.81 | 643.21 |
Total | 1,785.44 | 1,785.44 (as filed; total liabilities on the balance sheet are ₹19,329.60 lakh) |
Income Statement and Per-Share Data
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Revenue (INR Cr) | 242.38 | 109.30 | 3.43 | 2.32 | 4.73 |
Total expenses excl. D&A and interest (INR Cr) | 247.97 | 144.37 | 4.39 | 3.16 | 5.62 |
Gross profit (INR Cr) | 84.06 | 30.09 | 0.04 | 0.16 | 0.33 |
Operating profit / EBITDA (INR Cr) | -5.59 | -35.07 | -0.96 | -0.84 | -0.89 |
Other income incl. exceptional (INR Cr) | 15.76 | 0.15 | -62.91 | 14.92 | 0.48 |
Interest / finance cost (INR Cr) | 8.50 | 10.99 | 7.21 | 5.88 | 6.09 |
Depreciation (INR Cr) | 6.17 | 6.12 | 0.06 | 0.02 | 0.01 |
EBIT (INR Cr) | -11.76 | -41.19 | -1.02 | -0.86 | -0.90 |
Pre-tax income (INR Cr) | -4.50 | -52.03 | -71.14 | 8.18 | -6.51 |
Net income (INR Cr) | -4.69 | -51.88 | -71.14 | 8.19 | -6.52 |
EPS basic (INR) | -1.46 | -16.11 | -22.08 | 2.54 | -2.02 |
EPS diluted (INR) | -1.46 | -16.11 | -22.08 | 2.54 | -2.02 |
Dividend per share (INR) | 0 | 0 | 0 | 0 | 0 |
Margin Analysis (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Gross margin (%) | 34.7 | 27.5 | 1.2 | 6.9 | 7.0 |
EBITDA margin (%) | -2.31 | -32.09 | -27.99 | -36.21 | -18.82 |
Operating (EBIT) margin (%) | -4.9 | -37.7 | -29.7 | -37.1 | -19.0 |
Net margin (%) | -1.9 | -47.5 | -2,074.0 | 353.0 | -137.8 |
Income Statement
| Line item (INR Lakh) | Q4 FY2026 | FY2026 |
|---|---|---|
Revenue from operations | 88.96 | 473.22 |
Other income | 6.30 | 10.80 |
Purchases of stock-in-trade | 82.36 | 440.26 |
Employee benefit expense | 15.41 | 55.61 |
Finance costs | 192.71 | 607.95 |
Depreciation and amortisation | 0.32 | 1.42 |
Other expenses | 18.65 | 67.36 |
Profit before tax, continuing | -214.19 | -688.58 |
Profit after tax, discontinued | -61.55 | 36.96 |
Net profit, total | -275.74 | -651.62 |
Total comprehensive income | -275.31 | -651.35 |
Exceptional Item Details
| Exceptional item (INR Lakh) | FY2025 |
|---|---|
Profit on sale/discard of fixed assets / impairment on assets held for sale | 910.14 |
Provision for preference dividend written back | 1,494.86 |
Amortisation of preference-share issue expenses | -92.59 |
Inventory written off | -617.33 |
Total exceptional gain (net) | 1,695.08 |
Balance Sheet
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Total assets (INR Cr) | 187.04 | 134.80 | 45.33 | 18.92 | 17.85 |
Fixed assets net (INR Cr) | 127.73 | 120.88 | 26.81 | 0.42 | 0.40 |
Cash and short-term investments (INR Cr) | 0.06 | 0.44 | 0.43 | 0.82 | 1.71 |
Total borrowings (INR Cr) | 204.74 | 223.53 | 215.20 | 160.04 | 166.09 |
Net debt (INR Cr) | 204.68 | 223.09 | 214.77 | 159.22 | 164.38 |
Equity share capital (INR Cr) | 10.74 | 10.74 | 10.74 | 32.22 | 32.22 |
Reserves / other equity (INR Cr) | -109.25 | -161.20 | -232.62 | -201.15 | -207.66 |
Net worth (INR Cr) | -98.51 | -150.46 | -221.88 | -168.93 | -175.44 |
Goodwill and intangibles (INR Cr) | 0 | 0 | 0 | 0 | 0.03 |
Components
| Component | Amount |
|---|---|
Borrowings, current | 2,355.00 |
Borrowings, non-current | 14,250.00 |
Other non-current financial liabilities | 1,750.00 |
Liabilities in disposal group held for sale | 643.21 |
Trade payables | 50.14 |
Cash Flow
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Cash from operating activities (INR Cr) | -54.54 | -19.56 | -8.40 | -4.14 | -4.29 |
Cash from investing activities (INR Cr) | 18.53 | 2.14 | 11.91 | 23.89 | 2.78 |
Cash from financing activities (INR Cr) | 4.78 | 17.79 | -3.53 | -19.35 | 0.88 |
Net cash flow (INR Cr) | -31.23 | 0.38 | -0.01 | 0.40 | -0.63 |
Free cash flow as computed by Screener (INR Cr) | -36.03 | -17.52 | 3.97 | 19.39 | -0.22 |
Dividends paid (INR Cr) | 0 | 0 | 0 | 0 | 0 |
Buybacks (INR Cr) | 0 | 0 | 0 | 0 | 0 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
ROA (%) | -2.5 | -38.5 | -156.9 | 43.3 | -36.5 |
Interest coverage, EBIT/interest (x) | -1.38 | -3.75 | -0.14 | -0.15 | -0.15 |
Asset turnover (x) | 1.30 | 0.81 | 0.08 | 0.12 | 0.26 |
Net debt / revenue (x) | 0.84 | 2.04 | 62.6 | 68.6 | 34.8 |
Debtor days | 9.05 | 2.97 | 188.35 | 78.66 | 16.21 |
Inventory days | 93.82 | 38.44 | 690.16 | 0.00 | 0.00 |
Cash conversion cycle (days) | 6.82 | -37.13 | 76.38 | 78.66 | 16.21 |
ROCE as reported by Screener (%) | -9.38 | -45.86 | -3.01 | 0 | 0 |
Income Statement (Quarterly)
| Metric | Q2FY25 | Q3FY25 | Q4FY25 | Q1FY26 | Q2FY26 | Q3FY26 | Q4FY26 | Q1FY27 |
|---|---|---|---|---|---|---|---|---|
Sales (INR Cr) | 0.00 | 0.65 | 1.67 | 1.12 | 1.02 | 1.71 | 0.89 | 1.76 |
Operating profit (INR Cr) | -0.27 | -0.19 | -0.17 | -0.16 | -0.19 | -0.29 | -0.26 | -0.15 |
Interest (INR Cr) | 1.56 | 1.25 | 1.22 | 1.25 | 1.16 | 1.74 | 1.93 | 1.30 |
Net profit (INR Cr) | -3.11 | -1.81 | 6.96 | -1.76 | -1.78 | -0.21 | -2.76 | -1.80 |
Region revenue (INR Cr)
| Region revenue (INR Cr) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
India | 71.00 | 127.72 | 51.00 | 5.58 | 2.32 |
Export | 56.00 | 114.65 | 58.00 | 0 | 0 |
Total | 127.00 | 242.37 | 109.00 | 5.58 | 2.32 |
Region YoY growth (%)
| Region YoY growth (%) | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
India | 79.9 | -60.1 | -89.1 | -58.4 |
Export | 104.7 | -49.4 | -100.0 | 0 |
Valuation Snapshot
| Metric | Value | Source / date |
|---|---|---|
Last price (INR) | About 15.60 | ScanX, around 20 Oct 2026 |
Market cap (INR Cr) | About 50 | Analyst (32.22 M shares × ₹15.60); Screener ₹49.1 Cr at ₹15.9 (9 Oct 2026) |
52-week high / low (INR) | 24.3 / 11.3 | Screener, Oct 2026 |
Beta | About 0.54–0.70 | Sharpely; Equentis |
Analyst coverage | 0 analysts | Simply Wall St |
Return metric (%)
| Return metric (%) | 1 Year | 3 Year CAGR | 5 Year CAGR | 10 Year CAGR |
|---|---|---|---|---|
Share price return (%) | -34 | -6 | 0 | -14 |
Valuation Multiples
| Multiple | BPML | Peer context |
|---|---|---|
P/E (TTM) | Not meaningful (TTM loss ₹6.55 Cr) | JK Paper about 23× (Fyers, 2026 snapshot; column alignment uncertain) |
P/B | Negative (about –0.3×; book value about –₹54 per share) | Peers positive |
EV (INR Cr) | About 215 (₹50 Cr market cap + ₹164 Cr net debt incl. preference liability) | — |
EV/Sales (TTM) | About 40× (TTM revenue ₹5.38 Cr) | Simply Wall St cited P/S 14.9× vs Indian packaging industry average 0.7× (Dec 2025) |
EV/EBITDA | Not meaningful (negative EBITDA) | — |
Capital return (INR per share)
| Capital return (INR per share) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Dividend per share (INR) | 0 | 0 | 0 | 0 | 0 |
Credit Ratings
| Agency | Rating | Outlook | Date |
|---|---|---|---|
CRISIL | CRISIL BB / CRISIL A4+ (bank facilities) | Stable | Reaffirmed 29 Jan 2021 and 13 Apr 2022 |
CRISIL | Information-availability update | — | 21 Jun 2023, 12 Jul 2023 |
CRISIL | Withdrawn at company request on lender no-dues certificate | — | 18 Oct 2024 |
Moody's / S&P / Fitch | Not rated | — | — |
Bucket Details
| Bucket | Amount | Composition |
|---|---|---|
Within 12 months | 2,355.00 | Related-party ICDs (S P Finance ₹1,800; Sanchna ₹555); 1-year tenor, extendable |
Beyond 12 months | 14,250.00 | Primarily the ₹11,000 lakh 6.5% non-cumulative redeemable preference shares (analyst inference) plus other non-current borrowings |
Other non-current financial liabilities | 1,750.00 | Not itemised |
Total | 18,355.00 | — |
Analyst Conclusions
Management guidance and consensus
Management guidance: none quantitative. Qualitatively, management expects to improve the paper and paperboard trading business and to use "other available resources" for cash flow (FY2026 Note 3). The board has approved a real estate development business (April 2026).
Consensus: none. No sell-side coverage exists.
Bull case
-
Capital structure reset. NCLT sanction would cancel ₹110 Cr of preference capital (converted to a non-interest-bearing loan) and remove ₹52 Cr of accumulated losses. This could materially reduce reported finance costs, currently ₹6.08 Cr a year, and narrow losses toward the operating run-rate of about –₹0.9 Cr.
-
Land monetisation through real estate. If BPML retains developable Ambivali land in the Mumbai Metropolitan Region periphery, a joint development or outright development could create value well above the roughly ₹50 Cr market cap. The ₹180 lakh investment-property purchase in FY2026 shows real-estate activity has begun.
-
Sustained promoter support. ₹100 Cr of approved ICD headroom, a no-pledge stance and 59.95% promoter ownership indicate the group is unlikely to let the listed entity fail.
Bear case
-
Value accrues to creditors and promoters, not minorities. Liabilities of ₹193 Cr dwarf assets of ₹17.85 Cr. Any monetisation proceeds first service related-party ICDs and the deferred preference loan, both largely promoter-linked, leaving residual equity value uncertain.
-
Structural losses and going-concern doubt. Every year shows negative EBITDA. Finance costs exceed revenue. The auditor's qualification is repetitive, and Q1 FY2027 shows no improvement (loss ₹1.80 Cr).
-
Execution risk on every lever. The exchanges returned the scheme application in April 2026. The machinery sale was undelivered at FY2026 year-end. The real-estate business has no projects, staff or disclosed land bank.
Catalysts and monitorables (next 12 months)
| Catalyst / monitorable | Expected timing | Why it matters |
|---|---|---|
| Q2 FY2027 results | Oct–Nov 2026 | Finance cost and trading run-rate |
| Exchange no-objection and NCLT filing/sanction of the capital-reduction scheme | FY2027 (timing undisclosed) | Balance-sheet reset |
| Completion of the Symcom Exim machinery sale (₹10.9 Cr balance) | Overdue | Cash inflow; derecognition of held-for-sale assets |
| Disclosure of land title and real-estate project | Undated | Core of equity thesis |
| ICD drawdowns under the FY2027 limits | Ongoing | Measures promoter support and cash burn |
| Any change in auditor opinion | FY2027 audit (May 2027) | Going-concern signal |
| Cyber incident follow-up | Undated | Potential data-exposure liabilities |
Analyst verdict
Balkrishna Paper Mills is no longer an operating paper company. It is a restructuring situation wrapped in a listed shell.
-
The November 2024 closure of the Ambivali mill ended a decade of value destruction. In that decade, revenue fell from a peak of ₹242 Cr to under ₹5 Cr, and net worth deteriorated to –₹175 Cr.
-
What remains is a paper-trading activity earning a 7% gross spread on ₹4.7 Cr of sales. It sits beneath a ₹166 Cr stack of preference capital and promoter-group deposits, whose finance cost alone exceeds revenue.
-
The auditor's going-concern qualification is entirely warranted.
The equity's value therefore cannot be derived from earnings, cash flow or book value; all three are negative. It is an option on three contingent events:
-
NCLT sanction of the capital-reduction scheme. This would neutralise the ₹110 Cr preference liability and much of the finance cost.
-
Credible disclosure that BPML controls developable land. This would give substance to the April 2026 real-estate pivot.
-
Continued subordination of claims by the Poddar group. The group has funded every gap so far.
The governance profile demands caution. The Chair and MD roles are combined, funding is wholly related-party at up to 12%, and disclosure is minimal: no guidance, no investor communications, and an annual report that is hard to access. With no institutional holders and no analyst coverage, price discovery is shallow.
At about ₹50 Cr, the market is already paying for a meaningful probability that restructuring and land monetisation succeed. That price is not a clear mispricing in either direction. Investors who assign high odds to promoter-led asset monetisation may see the option as reasonably priced. Fundamentals-driven investors should treat BPML as uninvestable until three things happen:
-
the scheme is sanctioned;
-
the land position is disclosed; and
-
a funded real-estate project with identifiable economics is announced.
Our stance is Avoid / speculative only. The next two disclosures that would change it are the NCLT outcome and the first real-estate project announcement.
SOURCES (primary filings first)
-
NSE iXBRL Integrated Filing — FY2026 Audited Results, Balance Sheet, Cash Flow, RPT schedule (22 May 2026): nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_160452_22052026230251_iXBRL_WEB.html
-
NSE — Q3/9M FY2026 Unaudited Results with Limited Review (7 Feb 2026): nsearchives.nseindia.com/corporate/BALKRISHNA_07022026173321_UAFRason31122025.pdf
-
NSE iXBRL — Q2 FY2026 Results (14 Nov 2025): nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_128198_14112025185242_iXBRL_WEB.html
-
NSE — Intimation of IT Security Incident (15 Nov 2025): nsearchives.nseindia.com/corporate/BALKRISHNA_15112025175923_IntimationofITSecurityincident.pdf
-
NSE — Reg 30 Disposal of Ambivali machinery (14 Mar 2026): nsearchives.nseindia.com/corporate/BALKRISHNA_14032026161717_Reg30ofSEBILODR.pdf
-
NSE — Newspaper publication of FY2026 results (25 May 2026); Postal Ballot Notice (29 May 2026); PBN newspaper cutting (1 Jun 2026)
-
NSE/BSE — Rights issue filings (4 Jan 2024; 15 Mar 2024; 19 Apr 2024); CRPS redemption (9 May 2024); Board outcome 12 Jun 2023; Postal ballot results 14 Dec 2023
-
NSE — FY2022 Audited Results (24 May 2022): nsearchives.nseindia.com/corporate/AFR31032022_24052022144606.pdf
-
NSE — Promoter shareholding disclosure (8 Apr 2021)
-
BSE — Rights Issue Composite Application Form (Mar 2024)
-
CRISIL Ratings — BPML rationales (29 Jan 2021; 13 Apr 2022; 21 Jun 2023; 18 Oct 2024)
-
Screener.in — BPML standalone financials, shareholding, announcements (accessed Oct 2026)
-
StockAnalysis — BPML income statement and balance sheet (FY2022–FY2026)
-
MarketScreener — Segment, geographic, governance and event data
-
ScanX (Dhan) — Scheme of capital reduction (30 May and 20 Jun 2026); Real estate entry and ICDs (11 Apr 2026); Machinery disposal (14 Mar 2026); FY2026 loss (26 May 2026)
-
IIFL (indiainfoline) — Company summary; Directors' Report FY2025; Auditors' Report
-
Chittorgarh — Rights issue size and subscription data
-
Fyers — Peer comparison (2026 snapshot)
-
Simply Wall St; Kalkine; Value Research; ICICIdirect; Anand Rathi; 5paisa; Kotak Securities; Equentis; Sharpely; MarketsMOJO; TipRanks — market data
-
S&P Capital IQ via MarketScreener — Discontinuation announcement (13 Nov 2024)
-
Papermart — Machinery sale and CCI investigation reports
-
Breachsense — Third-party breach listing (26 Nov 2025)
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Executive Leadership Team
| Name | Title | Since | Background / notes | Compensation |
|---|---|---|---|---|
Anurag Pawankumar Poddar (DIN 00599143) | Chairman & Managing Director | 11 Feb 2015 | Promoter family (Siyaram–Poddar group). Aged about 45 per MarketScreener (age data date uncertain). Signs all results. | Not disclosed in retrieved RPT data; total pay not disclosed |
Manish Omkarmal Malpani (DIN 00055430) | Whole-time Director & CFO | Director from Aug 2023; WTD & CFO from 9 Dec 2023. Reappointed for 9 Dec 2026–8 Dec 2029 (board 22 May 2026; AGM 18 Sep 2026). | Born 1979 per Kalkine | ₹17.99 lakh remuneration for H2 FY2026 (Oct 2025–Mar 2026) |
Omprakash Singh (FCS 4304) | Company Secretary, Compliance Officer and Legal Head | 15 Oct 2015 | Born 1960 per Kalkine | ₹5.44 lakh for H2 FY2026 |
Board of Directors
| Director | Category | Notes | Sitting fees H2 FY2026 (INR Lakh) |
|---|---|---|---|
Anurag P. Poddar | Executive, Promoter (Chairman & MD) | Chair/CEO roles combined | — |
Ankit Poddar | Promoter-group director. Category per latest disclosures not confirmed; earlier AGM notices show retirement by rotation. | Elected chairman of the 19 Jun 2026 preference shareholders' EGM | — |
Manish O. Malpani | Executive (WTD & CFO) | See above | — |
Dileep H. Shinde (DIN 00270687) | Independent; Audit Committee Chairman | Appointed around Aug 2021 | 1.15 |
Dr. Mangesh D. Teli (DIN 00218899) | Independent | Appointed 9 Dec 2023 | 1.18 |
Ashok Nathmal Garodia | Independent | — | 0.90 |
| — | Non-Executive Non-Independent | Appointed via postal ballot, results 28 Mar 2025 | — |
“—” = not publicly disclosed.
Board & Management Changes
| Date | Change | Context |
|---|---|---|
8 May 2023 | Director exit | Board refresh preceding rights issue |
9 Dec 2023 | Previous CFO/director tenure ended; Malpani appointed WTD & CFO; Dr. Teli appointed ID | Pre-rights-issue governance refresh |
28 Mar 2025 | Woman Non-Executive director and an Independent Director appointed | Compliance with board-diversity norms |
22 May 2026 / 18 Sep 2026 | Malpani reappointment recommended / approved | Continuity through restructuring |
Shareholding Trend
| Shareholder category (%) | Jun 2024 | Mar 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Promoter and promoter group | 59.95 | 59.95 | 59.95 | 59.95 |
FIIs | 0.01 | 0.00 | 0.00 | 0.00 |
DIIs | 0.00 | 0.03 | 0.03 | 0.03 |
Public | 40.04 | 40.02 | 40.03 | 40.01 |
Number of shareholders (count) | 14,767 | 15,516 | 14,836 | 14,565 |
Competitive Landscape
Peer Comparison FY2026
| Company | Segment overlap | Market cap (INR Cr) | Annual PAT (INR Cr) | Revenue | Positioning vs BPML |
|---|---|---|---|---|---|
JK Paper Ltd | Packaging board (incl. Sirpur, Cepac), writing and printing | 7,440 | 266 | — | Integrated leader; >100× BPML's scale |
West Coast Paper Mills | Writing and printing, packaging | 4,337 | 151 | — | Integrated, wood-based |
Seshasayee Paper & Boards | Writing/printing, boards | 1,484 | 83 | — | Profitable mid-cap |
Andhra Paper | Writing/printing, board | 1,260 | 19 | — | Large mill |
Tamil Nadu Newsprint & Papers (TNPL) | Packaging board, writing/printing | 1,069 | 248 | — | State-owned, large board capacity |
Pudumjee Paper Products | Specialty paper | 900 | 94 | — | Niche specialty |
N R Agarwal Industries | Duplex board, newsprint (recycled) | 848 | 44 | — | Closest legacy peer: recycled duplex board in western India |
Emami Paper Mills | Duplex board, newsprint | 681 | 61 | — | Recycled-fibre board peer |
Kuantum Papers | Writing/printing (agro-based) | 663 | 42 | — | Regional |
Satia Industries | Writing/printing (agro-based) | 609 | 41 | — | Regional |
ITC (Paperboards & Specialty Papers division) | Virgin and recycled board | Part of ITC Ltd | Not separable | — | Dominant premium board player |
Balkrishna Paper Mills | Paper/board trading | 57 | -7 | 4.73 (FY2026) | Distressed micro-cap |
Peer Comparison FY2026 — Market cap
| Metric | BPML | JK Paper | West Coast Paper | Seshasayee Paper |
|---|---|---|---|---|
Market cap (INR Cr) | 57 | 7,440 | 4,337 | 1,484 |
Annual PAT (INR Cr) | -7 | 266 | 151 | 83 |
Revenue growth | +104% FY2026 (tiny base) | — | — | — |
EBITDA margin | -18.8% FY2026 | — | — | — |



